Risk assessment considerations for veterinary medicines in aquatic ecosystems

ACS Symposium Series

Volumn 1018, Issue , 2009, Pages 205-223

  Brooks, Bryan W ^a   Brain, Richard A ^a   Huggett, Duane B ^b   Ankley, Gerald T ^c  

^a BAYLOR UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAZARDS; INTERNATIONAL COOPERATION; VETERINARY MEDICINE;

ASSESSMENT APPROACHES; BIOLOGICAL PROPERTIES; ECOLOGICAL RISK ASSESSMENT; PROBABILISTIC APPROACHES; RISK CHARACTERIZATION; TECHNICAL REQUIREMENT; TIERED RISK ASSESSMENT; VETERINARY MEDICINAL PRODUCTS;

RISK ASSESSMENT;

EID: 84905578509     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2009-1018.ch014     Document Type: Conference Paper

References (60)

1. Boxall, A.B.A.; Fogg, L.A.; Blackwell, P.A.; Kay, P.; Pemberton, E.J.; Croxford, A. Veterinary medicines in the environment. Rev. Environ. Contam. Toxicol. 2004, 180, 1-91.
2. Ankley, G.T.; Jensen, K.M.; Makynen, E.A.; Kahl, M.D.; Korte, J.J.; Hornung, M.W.; Henry, T.R.; Denny, J.S.; Leino, R.L.; Wilson, V.S.; Cardon, M.C.; Hartig, P.C.; Gray, L.E. Effects of the androgenic growth promoter 17-beta-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. Environ. Toxicol. Chem. 2003, 22, 1350-1360.
3. Sanderson, H.; Laird B.; Pope L.; Brain R.; Wilson C.; Johnson D.; Bryning G.; Peregrine, A.S.; Boxall, A.; Solomon, K.R. Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms. Aquat. Toxicol. 2007, 85, 229-240.
4. VICH. Environmental impact assessment (EIAs) for veterinary medicinal products (Veterinary medicines) - Phase 1. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. VICH-GL6 (Ecotoxicity Phase I). 2000.
5. VICH. Environmental Impact Assessment for Veterinary Medicinal Products: Phase II Guidance. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. VICH-GL38 (Ecotoxicity Phase II). 2004.
6. Ankley, G.T.; Jensen, K.M.; Kahl, M.D.; Korte, J.J.; Makynen, E.A. Description and evaluation of a short-term reproduction test with the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 2001, 20, 1276-1290.
7. Daughton, C.G.; Ternes, T.A. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 1999, 107(Suppl 6), 907-938.
8. Brooks, B.W.; Ankley, G.; Hobson, J.; Meyerhoff, R.; Lazorchak, J.; Solomon, K. Aquatic Hazard Assessment of Veterinary Medicines. In Veterinary Medicines in the Environment; Crane, M.; Barrett, K.; Boxall, A., Eds; SETAC Press: Pensacola, FL; 2008; In press.
9. Ankley, G.L.; Brooks, B.W.; Huggett, D.B.; Sumpter, J. Repeating history: pharmaceuticals in the environment. Environ. Sci. Technol. 2007, 41, 8211- 8217.
10. Durhan, E.J.; Lambright, C.S.; Makynen, E.A.; Lazorchak, J.; Hartig, P.C.; Wilson, V.S.; Gray, L.E.; Ankley, G.T. Identification of metabolites of trenbolone acetate in androgenic runoff from a beef feedlot. Environ. Health Perspect. 2006, 114(Suppl. 1): 65-68.
11. Kidd, K.A.; Blanchfield, P.J.; Mills, K.H.; Palace, V.P.; Evans, R.E.; Lazorchak, J.M.; Flick, R.W. Collapse of a fish population after exposure to a synthetic estrogen. Proc. Natl. Acad. Sci. USA 2007, 104, 8897-8901.
12. Clubbs, R.L.; Brooks, B.W. Daphnia magna responses to a vertebrate estrogen receptor agonist and an antagonist: A multigenerational study. Ecotox. Environ. Saf. 2007, 67, 385-398.
13. Metcalfe, C.; Boxall, A.; Fenner, K.; Kolpin, D.; Servos, M.; Silberhorn, E.; Staveley, J. Exposure Assessment of Veterinary Medicines in Aquatic Systems. In Veterinary Medicines in the Environment; Crane, M.; Barrett, K.; Boxall, A.; Eds. SETAC Press: Pensacola, FL; 2008, In Press.
14. Brooks, B.W.; Maul, J.; Belden, J.B. Emerging contaminants: Antibiotics in aquatic and terrestrial ecosystems. In Encyclopedia of Ecology; Jorgensen, S.E., Ed; Elsevier: Oxford, UK; 2008; In press.
15. Holthaus, K.I.E.; Johnson, A.C.; Jurgens, M.D.; Williams, R.J.; Carter, J.E. The potential for estradiol and ethinylestradiol to sorb to suspended and bed-sediments in some English rivers. Environ. Toxicol. Chem. 2002, 21, 2526-2535.
16. Kummerer, K.; Ericson, J.F.; Hannah, R.; Johnson, A.; Sedlak, D.L.; Weston, J.J. Environmental fate and transport of human pharmaceuticals. In Human pharmaceuticals: Assessing the impacts on aquatic ecosystems; Williams, R.T., Ed. SETAC Press: Pensacola, FL; 2005; p. 111-148.
17. Belden, J.B.; Maul, J.D.; Lydy, M.J. Partitioning and photodegradation of ciprofloxacin in aqueous systems in the presence of organic matter. Chemosphere 2007, 66, 1390-1395.
18. Fent, K. Ecotoxicology of organotin compounds. Crit. Rev. Toxicol. 1995, 26, 1-117.
19. Blackman, G.E.; Robertson-Cunningham, R.C. The influence of pH on the phytotoxicity of 2:4-dichlorophenxyacetic acid to Lemna minor. New Phytologist 1953, 52, 71-75.
20. United States Environmental Protection Agency. 1999 update of ambient water quality criteria for ammonia. Office of Water. United States Environmental Protection Agency; Washington, DC. EPA-822-R-99-014. 1999.
21. United States Environmental Protection Agency. Ambient water quality criteria for pentachlorophenol- 1986. Office of Regulations and Standards, Criteria and Standards Division. United States Environmental Protection Agency; Washington, DC. EPA-440-5-86-009. 1986.
22. Orvos, D.R.; Versteeg, D.J.; Inauen, J.; Capdevielle, M.; Rothenstein, A.; Cunningham, V. Aquatic toxicity of triclosan. Environ. Toxicol. Chem. 2002, 21, 1338-1349.
23. Furlong, E.T.; Kinney, C.A.; Burkhardt, M.R.; Zaugg, S.D.; Werner, S.L. Organic wastewater contaminants in biosolids and biosolid-derived products. In Abstracts with Programs; Geological Society of America Meeting, Seattle, WA; 2003, 35, 149.
24. Johnson, D.J.; Sanderson, H.; Brain, R.A.; Wilson, C.J.; Bestari, K.J.T.; Solomon, K.R. Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. Regul. Toxicol. Pharmacol. 2005, 42, 313-323.
25. Kwon, J.W.; Armbrust, K.L. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ. Toxicol. Chem. 2006, 25, 2561-2568.
26. Brooks, B.W.; Chambliss, C.K.; Stanley, J.K.; Ramirez, A.J.; Banks, K.E.; Johnson, R.D.; Lewis, R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24, 464- 469.
27. Geary, P.M.; Davies, C.M. Bacterial source tracking and shellfish contamination in a coastal catchment. Water Sci. Technol. 2003, 47, 95-100.
28. McFarland, A.M.S.; L. Hauck. Relating agricultural land uses to in-stream stormwater quality. J. Environ. Qual. 1999, 28, 836-844.
29. Orlando, E.F.; Kolok, A.S.; Binzcik, G.A.; Gates, J.L.; Horton, M.K.; Lambright, C.S.; Gray, L.E.; Soto, A.M.; Guillette, L. Endocrinedisrupting effects of cattle feedlot effluent on an aquatic sentinel species, the fathead minnow. Environ. Health Perspect. 2004, 112, 353-358.
30. Yang, S.W.; Carlson, K. Evolution of antibiotic occurrence in a river through pristine, urban and agricultural landscapes. Water Res. 2003, 37, 4645-4656.
31. Prochnow, S.J.; White, J.D.; Scott, T.;Filstrup, C. Small reservoir impact on watershed-scale simulated nutrient loads. 2008, accepted.
32. Arnold, J.G.; Fohrer, N. SWAT2000: Current capabilities and research opportunities in applied watershed modeling. Hydrological Processes 2005, 19, 563-572.
33. de Knect, J.; Boucard, T.; Brooks, B.; Crane, M.; Gerould, S.; Koschorreck, J.; Scheef, G.; Solomon, K.; Zhixing, Y. Environmental risk assessment of veterinary medicines. In Veterinary Medicines in the Environment; Crane, M.; Barrett, K.; Boxall, A.; Eds. SETAC Press: Pensacola, FL; 2008, In Press.
34. Brooks, B.W.; Riley, T.M.; Taylor, R.D. Water quality of effluentdominated stream ecosystems: ecotoxicological, hydrological, and management considerations. Hydrobiologia 2006, 556, 365-379.
35. United States Environmental Protection Agency. Overview of the Ecological Risk Assessment Processin the Office of Pesticide Programs, U.S. Environmental Protection Agency: Endangered and Threatened Species Effects Determinations. Office of Prevention, Pesticides and Toxic Substances Office of Pesticide Programs. United States Environmental Protection Agency; Washington, DC. 2004.
36. Davy, M.; Petrie, R.; Smrchek, J.; Kuchnicki, T.; Francois, D. Proposal to update non-target plant toxicity testing under NAFTA. US Environmental Protection Agency; Washington, DC; 2001; http://www.epa.gov/scipoly/sap/158 p.
37. Ankley, G.T.; Black, M.C.; Garric, J.; Hutchinson, T.H.; Iguchi, T. A framework for assessing the hazard of pharmaceutical materials to aquatic species. In Human pharmaceuticals: Assessing the impacts on aquatic ecosystems; Williams, R.T., Ed.; SETAC Press: Pensacola, FL; 2005; pp 183-237.
38. Hutchinson, T. H.; Ankley, G. T.; Segner, H.; Tyler, C. R. Screening and testing for endocrine disruption in fish -biomarkers as "signposts, " not "traffic lights" in risk assessment. Environ. Health Perspect. 2006, 116(Suppl. 1), 106-114.
39. United States Food and Drug Administration. Resources for drug registration studies. Available at http://www.fda.gov/ceder/guidance. 2002.
40. Gould, G.G.; Brooks, B.W.; Frazer, A. Citalopram binding to serotonin transporter sites in minnow brains. Basic Clin. Pharmacol. Toxicol. 2007, 101, 203-210.
41. Fong, P.; Huminski, P.; D'Urso, L. Induction and potentiation of parturition in fingernail clams by selective serotonin re-uptake inhibitors. J. Exp. Zool. 1998, 280, 260-264.
42. Huggett, D. B.; Cook, J.C.; Ericson, J.E.; Williams, R.T. Theoretical model for prioritizing potential impacts of human pharmaceuticals to fish. J. Human Eco. Risk Ass. 2003, 9, 1789-1799.
43. Huggett, D.B.; Benson, W.H.; Chipman, K.; Cook, J.C.; Gray, L.E.; Kinter, L.B.; Meyerhoff, R.D.; Trudeau, V.L. Role of mammalian data in determining pharmaceutical responses in aquatic species. In Human pharmaceuticals: Assessing the impacts on aquatic ecosystems; Williams, R.T., Ed. SETAC Press: Pensacola, FL; 2005; p. 149-181.
44. Fitzsimmons, P.N.; Fernadez, J.D.; Hoffman, A.D.; et al. Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2001, 55, 23-34.
45. Ramirez, A.J.; Mottaleb, M.A.; Brooks, B.W.; Chambliss, C.K. Analysis of pharmaceuticals in fish tissue using liquid chromatography - Tandem mass spectrometry. Anal. Chem. 2007, 79, 3155-3163.
46. Brown, J.N.; Paxéus, N.; Förlin, L.; Larsson, D.G.J. Variations of bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Pharmacol. 2007, 24, 267-274.
47. MacGregor, J.T. The future of regulatory toxicology: impact of the biotechnology revolution. Toxicol. Sci. 2003, 75, 236-248.
48. Waters, M.D.; Fostel, J.M. Toxicogenomics and systems toxicology: Aims and prospects. Nature Rev Genetics 2004, 5, 936-948.
49. Lettieri, T. Recent applications of DNA microarray technology to toxicology and ecotoxicology. Environ. Health Perspect. 2006, 114, 4-9.
50. Ahituv, N.; Rubin, E.M.; Nobrega, M.A. Exploiting human-fish genome comparisons for deciphering gene regulation Human. Mol. Genet. 2004, 13, R261-R266.
51. Ankley, G. T.; Daston, G. P.; Degitz, S. J.; Denslow, N. D.; Hoke, R. A.; Kennedy, S. W.; Miracle, A. L.; Perkins, E. J.; Snape, J.; Tillitt, D. E.; Tyler, C. R.; Versteeg, D. Toxicogenomics in regulatory ecotoxicology. Environ. Sci. Technol. 2006, 40, 4055-4065.
52. Solomon, K.R.; Takacs, P. Probabilistic risk assessment using species sensitivity distributions. In Species Sensitivity Distributions in Risk Assessment; Posthuma, L.; Traas, T.; Suter, G.; Ed. CRC Press: Boca Raton, FL; 2002.
53. Stephan, C.E.; Mount, D.I.; Hansen, D.J.; Gentile, J.H.; Chapman, G.A.; Brungs, W.A. Guidelines for deriving numerical national water quality criteria for the protection of aquatic organisms and their uses. US EPA ORD ERL; Duluth MN. PB 85-227049: 1985. p 97.
54. Stephan, C.E. Use of species sensitivity distributions in the derivation of water quality criteria for aquatic life by the U.S. Environmental Protection Agency. In Species Sensitivity Distributions in Risk Assessment; Posthuma, L.; Traas, T.; Suter, G.; Eds. CRC Press: Boca Raton, FL. 2002. p 564.
55. EMEA. Committee for Medicinal products for Veterinary Use (CVMP): Guideline on Environmental Impact Assessment for Veterinary Medicinal Products Phase II. 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK: European Medicines Agency Veterinary Medicines and Inspections. CVMP/VICH/790/03-FINAL. 2004.
56. EMEA. Committee for Medicinal Products for Human Use (CHMP): Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 7 Westferry Circus, Canary Wharf, London E14 4HB, UK: European Medicines AF. 2004.
57. Solomon, K.R.; Gipsy, J.P.; Jones, P. Probabilistic risk assessment of agrochemicals in the environment. Crop Protect. 2000, 19, 649-655.
58. Brain, R.A.; Sanderson, H.; Sibley, P.K.; Solomon, K.R. Probabilistic ecological hazard assessment: Evaluating pharmaceutical effects on aquatic higher plants as an example. Ecotox. Environ. Saf. 2006, 64, 128-135.
59. Hanson, M.L.; Solomon, K.R. New technique for estimating thresholds of toxicity in ecological risk assessment. Environ. Sci. Technol. 2002, 36, 3257-3264.
60. Grist, E.P.M.; Leung, K.M.Y.; Wheeler, J.R.; Crane, M. Better bootstrap estimation of hazardous concentration thresholds for aquatic assemblages. Environ. Toxicol. Chem. 2002, 21, 1515-1524.